Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2732182 | 0.92 | TSHR (0.55) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL28554486 | 0.88 | TSHR (0.50) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL26780359 | 0.87 | SMN1; SMN2 (0.51) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL17373030 | 0.86 | TSHR (0.52) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL26780305 | 0.85 | TSHR (0.47) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL18707711 | 0.85 | TSHR (0.47) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL23701339 | 0.84 | TSHR (0.46) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL11290142 | 0.84 | TSHR (0.46) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL2018047 | 0.84 | TSHR (0.46) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 | |
| SCHEMBL1461621 | 0.83 | TSHR (0.45) | TSHRSMN1; SMN2ALDH1A1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368774-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2025-12-04 | — | — | US | disclosed |
| US-20240191078-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2024-06-13 | — | — | US | disclosed |
| US-20240174889-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2024-05-30 | — | — | US | disclosed |
| WO-2023224118-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2023-11-23 | — | — | WO | disclosed |
| WO-2022202498-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022203042-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022102626-A1 | ULTRAVIOLET RAY CURABLE COMPOSITION AND APPLICATIONS THEREOF | ダウ・東レ株式会社 | 2022-05-19 | — | — | WO | disclosed |
| EP-1132407-B1 | Hydrophobically modified cellulose ethers, process for their preparation and their use | SE TYLOSE GMBH & CO KG (DE) | 2004-07-28 | — | — | EP | disclosed |
| US-20010021387-A1 | Hydrophobically modified cellulose ethers, their preparation and use | CLARIANT GMBH | 2001-09-13 | — | — | US | disclosed |
| EP-1132407-A1 | Hydrophobically modified cellulose ethers, process for their preparation and their use | Clariant GmbH (DE) | 2001-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010021387-A1 | Hydrophobically modified cellulose ethers, their preparation and use | LCT, SI, CLSPN | TSHR 4850/4885SMN1; SMN2 1593/4885ALDH1A1 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.